Top Markets
Coin of the day
BioNexus Gene Lab Corp. BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp.

BGLC
Kedudukan dalam Saham #35594
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Harga Saham
$1.50
Disegerakkan terakhir: 2026-09-21
Modal Pasaran
$3.63M
Perubahan (1 hari)
-4.46%
Perubahan (1 tahun)
-72.68%
Negara
MY
Perdagangan BioNexus Gene Lab Corp. (BGLC)

Kategori

Bilangan saham terbitan bagi BioNexus Gene Lab Corp. (BGLC)
Bilangan saham terbitan setakat June 2026: 2.42M
Menurut laporan kewangan terkini dan harga saham BioNexus Gene Lab Corp., bilangan saham terbitan semasa ialah 2.42M. Pada akhir December 2023, syarikat mempunyai 1.72M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk BioNexus Gene Lab Corp. (BGLC) dari 2016 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 2.42M 35.66%
2024 1.78M 3.47%
2023 1.72M 19.51%
2022 1.44M 0.99%
2021 1.43M 66.36%
2020 857.65K 19.16%
2019 719.74K 30.20%
2018 552.80K -11.11%
2017 621.90K 0.00%
2016 621.90K 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
47.30M 1,856.72%
US
1.15B 47,374.18%
US
- -
US
49.50M 1,947.73%
US
- -
US